Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association

被引:189
作者
Pop-Busui, Rodica [1 ]
Januzzi, James L. [2 ,3 ]
Bruemmer, Dennis [4 ]
Butalia, Sonia [5 ,6 ]
Green, Jennifer B. [7 ,8 ]
Horton, William B. [9 ]
Knight, Colette [10 ]
Levi, Moshe [11 ]
Rasouli, Neda [12 ]
Richardson, Caroline R. [13 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA
[2] Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02114 USA
[3] Baim Inst Clin Res, Cardiometab Trials, Boston, MA USA
[4] Cleveland Clin Fdn, Ctr Cardiometab Hlth, Robert & Suzanne Tomsich Dept Cardiovasc Med, Sect Prevent Cardiol & Rehabil, 9500 Euclid Ave, Cleveland, OH 44195 USA
[5] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada
[6] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada
[7] Duke Univ, Med Ctr, Dept Med, Div Endocrinol, Durham, NC 27710 USA
[8] Duke Univ, Med Ctr, Dept Med, Duke Clin Res Inst, Durham, NC 27710 USA
[9] Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA USA
[10] Hackensack Univ, Hackensack Meridian Sch Med, Med Ctr, Inserra Family Diabet Inst, Hackensack, NJ USA
[11] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA
[12] Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA
[13] Univ Michigan, Med Sch, Dept Family Med, Ann Arbor, MI 48109 USA
关键词
CORONARY MICROVASCULAR DYSFUNCTION; COTRANSPORTER; 2; INHIBITORS; BASE-LINE CHARACTERISTICS; OF-CARDIOLOGY FOUNDATION; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR OUTCOMES; NATRIURETIC PEPTIDE; EMERGENCY-DEPARTMENT; EJECTION FRACTION; RISK-FACTORS;
D O I
10.2337/dci22-0014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) has been recognized as a common complication of diabetes, with a prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data also suggest that HF may develop in individuals with diabetes even in the absence of hypertension, coronary heart disease, or valvular heart disease and, as such, represents a major cardiovascular complication in this vulnerable population; HF may also be the first presentation of cardiovascular disease in many individuals with diabetes. Given that during the past decade, the prevalence of diabetes (particularly type 2 diabetes) has risen by 30% globally (with prevalence expected to increase further), the burden of HF on the health care system will continue to rise. The scope of this American Diabetes Association consensus report with designated representation from the American College of Cardiology is to provide clear guidance to practitioners on the best approaches for screening and diagnosing HF in individuals with diabetes or prediabetes, with the goal to ensure access to optimal, evidence-based management for all and to mitigate the risks of serious complications, leveraging prior policy statements by the American College of Cardiology and American Heart Association.
引用
收藏
页码:1670 / 1690
页数:21
相关论文
共 211 条
  • [1] Long-term mortality after gastric bypass surgery
    Adams, Ted D.
    Gress, Richard E.
    Smith, Sherman C.
    Halverson, R. Chad
    Simper, Steven C.
    Rosamond, Wayne D.
    LaMonte, Michael J.
    Stroup, Antoinette M.
    Hunt, Steven C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08) : 753 - 761
  • [2] Al-Khatib SM, 2018, CIRCULATION, V138, pE272, DOI [10.1161/CIR.0000000000000548, 10.1161/CIR.0000000000000549]
  • [3] Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure
    ALZadjali, Matlooba A.
    Godfrey, Valerie
    Khan, Faisel
    Choy, AnnaMaria
    Doney, Alexander S.
    Wong, Aaron K.
    Petrie, John R.
    Struthers, Allan D.
    Lang, Chim C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (09) : 747 - 753
  • [7] 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S144 - S174
  • [8] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1451 - 1461
  • [9] Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Shahzeb Khan, Muhammad
    Pedro Ferreira, Joao
    Bocchi, Edimar
    Bohm, Michael
    Pieter Brunner-La Rocca, Hans
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio, V
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Seronde, Marie-France
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (12) : 2383 - 2392
  • [10] Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status Results From the EMPEROR-Reduced Trial
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Khan, Muhammad Shahzeb
    Marx, Nikolaus
    Lam, Carolyn S. P.
    Schnaidt, Sven
    Ofstad, Anne Pernille
    Brueckmann, Martina
    Jamal, Waheed
    Bocchi, Edimar A.
    Ponikowski, Piotr
    Perrone, Sergio, V
    Januzzi, James L.
    Verma, Subodh
    Boehm, Michael
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. CIRCULATION, 2021, 143 (04) : 337 - 349